The Feasibility of Following the Crohn's Diet
1 other identifier
interventional
20
1 country
1
Brief Summary
A research team from King's College London are investigating how diet can be used as a treatment for Crohn's disease. The investigators have designed a new diet and eventually wish to test whether the diet can be used to manage Crohn's disease and reduce gut inflammation. Before doing this, the investigators need to find out how practical it is for people to follow the diet for 14 days by conducting this 'feasibility' study. A feasibility study is a small study that aims to highlight any issues before informing the design of a larger research trial. The diet the investigators have designed is called the Crohn's Diet. The evidence for this diet is based on recent research which suggests that certain food ingredients may be involved in triggering gut inflammation. The study's primary aim is to assess the practicalities of following the Crohn's Diet. It will also assess compliance to the Crohn's Diet and if following it changes the nutritional balance from the normal diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2018
CompletedFirst Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2018
CompletedFebruary 26, 2019
February 1, 2019
5 months
September 20, 2018
February 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of following the Crohn's Diet: questionnaire
Method: Collation of participant feedback during the Crohn's Diet and administer diet feasibility questionnaire. This questionnaire uses an adapted Education Method Usability Scale (Bangor et al. 2008) ('strongly agree' to 'strongly disagree' style scale) and open questions.
Throughout the 14-day intervention
Secondary Outcomes (6)
Acceptability of following the Crohn's Diet: questionnaire
Throughout the 14-day intervention and within one week of completing the intervention
Participant compliance to the Crohn's Diet
Throughout the 14-day intervention
Impact of the Crohn's Diet on habitual dietary intake
One week before the intervention and throughout the 14-day intervention
Impact of the Crohn's Diet on BMI
One week before the intervention and within one week of completing the 14-day intervention
Impact of the Crohn's Diet on gastrointestinal symptoms
One week before the intervention and within one week of completing the 14-day intervention
- +1 more secondary outcomes
Interventions
All recruited participants will be educated on the Crohn's Diet and instructed to adhere to the study diet for 14 days.
Eligibility Criteria
You may qualify if:
- Adults aged ≥18 years with a diagnosis of Crohn's disease
- Stable Crohn's disease (as defined as self-reported: no change in Crohn's disease medication in the last 3 months; no Crohn's disease surgery in the last 6 months; no hospital admissions related to Crohn's disease in the last 6 months; no new perianal Crohn's disease in the last 6 months).
- Individuals with a Body Mass Index (BMI) of ≥ 18.5 kg/m2
- Individuals able to give informed consent
- Individuals able to understand and read English
- Individuals willing to provide consent in this study which involves a dietary change for 14 days
You may not qualify if:
- Unexplained/unintentional weight loss in the past 6 months
- Major co-morbidities; for example, diabetes, coeliac disease, major active psychiatric conditions or current eating disorders.
- Current Crohn's disease therapy with any of the following: corticosteroids, exclusive or partial enteral nutrition (liquid nutrition), and any participants prescribed oral nutrition supplements for nutrition support.
- Individuals who report to be pregnant or lactating
- Individuals with specific, complex dietary needs (based on the dietitian's judgment), such as multiple food allergies, in which the additional burden of the Crohn's Diet would pose a nutrition risk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King's College London
London, SE1 9NH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Whelan
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2018
First Posted
October 1, 2018
Study Start
July 8, 2018
Primary Completion
December 18, 2018
Study Completion
December 18, 2018
Last Updated
February 26, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share